Clinical trial
rhPTH Therapy for Low Turnover Bone Fragility
NCT00145886 · University of Chicago, Other · Terminated
Key facts
| NCT number | NCT00145886 |
|---|---|
| Title | rhPTH Therapy for Low Turnover Bone Fragility |
| Official title | Effect of 12 Months Treatment With rhPTH on Calcium Balance, Bone Turnover, Bone Mineral Density, and Bone Micro-architecture in Patients With Fractures Associated With Low Bone Turnover and Sclerosing Bone Disorders |
| Lead sponsor | University of Chicago, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteopetrosis |
| Intervention type | Drug |
| Interventions | rhPTH |
| Enrollment | 2 |
| Start date | Feb 1, 2003 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Sep 5, 2005 |
| Last update posted | Jan 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: